echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Japan completes first living donor lung transplant for patients with new coronary pneumonia

    Japan completes first living donor lung transplant for patients with new coronary pneumonia

    • Last Update: 2021-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Kyoto University Hospital in Japan said on April 8th local time that a patient with new coronary pneumonia who had been treated for about 3 months had been transplanted with a lung provided by his family.


    According to Kyoto University Hospital, the recipient of the lung transplant was a female patient living in Kansai.


    The patient was transferred to Kyoto University Hospital on the 5th of this month due to an application for organ donation from his family.


    This article is from Bio Valley, for more information, please download the Bio Valley APP (

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.